• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Vav3 癌基因上调前列腺癌细胞雄激素受体活性的分子机制。

The molecular mechanism of Vav3 oncogene on upregulation of androgen receptor activity in prostate cancer cells.

机构信息

Department of Pathology, University of Cincinnati College of Medicine, the Metabolic Diseases Institute, Cincinnati, OH 45237, USA.

出版信息

Int J Oncol. 2010 Mar;36(3):623-33. doi: 10.3892/ijo_00000538.

DOI:10.3892/ijo_00000538
PMID:20126983
Abstract

Our previous studies revealed that Vav3 oncogene is overexpressed in human prostate cancer, enhances androgen receptor (AR)-mediated signaling, and may play a role in prostate cancer development and progression. The purpose of this study was to determine the molecular mechanisms responsible for AR activation by Vav3. We found that interaction between N-terminus and C-terminus of AR is essential for its elevated activity stimulated by Vav3. The DH and PH domains of Vav3 are involved in direct interaction with AR. Both cytoplasmic and nuclear levels of AR and Vav3 are elevated and their nuclear localization is further stimulated by DHT in androgen-independent LNCaP-AI cells relative to their parental androgen-dependent LNCaP cells. Vav3 is colocalized with AR, phospho(P)-Akt, and HER2 with a short term stimulation by EGF and DHT. PI3K inhibitor LY294002 blocks colocalization of Vav3 with P-Akt. Consistently, EGF and DHT stimulate Vav3 and AR interaction and enhance PI3K-Akt signaling. Mutation of tyrosines to phenylalanines in the acidic domain or deletion of the SH2 and SH3 domains significantly enhances Vav3 ability for AR activation, while deletion of the DH domain abolishes this activity. Given that an elevated interaction of Vav3 with AR, P-Akt, and HER2 in both cytoplasm and nucleus upon the short-term of DHT stimulation, our data suggest that Vav3 may enhance non-genomic AR activity via PI3K-Akt signaling in addition to AR transcriptional activity and further support a role in androgen-independent growth in prostate cancer.

摘要

我们之前的研究表明,Vav3 癌基因在人前列腺癌中过度表达,增强了雄激素受体(AR)介导的信号转导,可能在前列腺癌的发展和进展中发挥作用。本研究的目的是确定 Vav3 激活 AR 的分子机制。我们发现,AR 的 N 端和 C 端之间的相互作用对于 Vav3 刺激的其活性升高是必需的。Vav3 的 DH 和 PH 结构域参与与 AR 的直接相互作用。与亲本雄激素依赖性 LNCaP 细胞相比,雄激素非依赖性 LNCaP-AI 细胞中 AR 和 Vav3 的细胞质和核水平升高,其核定位进一步受到 DHT 的刺激。Vav3 与 AR、磷酸化(P)-Akt 和 HER2 共定位,短期受到 EGF 和 DHT 的刺激。PI3K 抑制剂 LY294002 阻断 Vav3 与 P-Akt 的共定位。一致地,EGF 和 DHT 刺激 Vav3 和 AR 相互作用,并增强 PI3K-Akt 信号。在酸性结构域中的酪氨酸突变为苯丙氨酸或缺失 SH2 和 SH3 结构域显著增强了 Vav3 激活 AR 的能力,而 DH 结构域的缺失则消除了这种活性。鉴于 Vav3 与 AR、P-Akt 和 HER2 在细胞质和核中的相互作用在 DHT 刺激的短期时间内升高,我们的数据表明,Vav3 可能通过 PI3K-Akt 信号通路增强非基因组 AR 活性,除了 AR 转录活性,并进一步支持其在前列腺癌中雄激素非依赖性生长中的作用。

相似文献

1
The molecular mechanism of Vav3 oncogene on upregulation of androgen receptor activity in prostate cancer cells.Vav3 癌基因上调前列腺癌细胞雄激素受体活性的分子机制。
Int J Oncol. 2010 Mar;36(3):623-33. doi: 10.3892/ijo_00000538.
2
Vav3 oncogene is overexpressed and regulates cell growth and androgen receptor activity in human prostate cancer.Vav3癌基因在人类前列腺癌中过度表达,并调节细胞生长和雄激素受体活性。
Mol Endocrinol. 2006 Oct;20(10):2315-25. doi: 10.1210/me.2006-0048. Epub 2006 Jun 8.
3
Vav3, a Rho GTPase guanine nucleotide exchange factor, increases during progression to androgen independence in prostate cancer cells and potentiates androgen receptor transcriptional activity.Vav3是一种Rho GTPase鸟嘌呤核苷酸交换因子,在前列腺癌细胞向雄激素非依赖性进展过程中表达增加,并增强雄激素受体的转录活性。
Mol Endocrinol. 2006 May;20(5):1061-72. doi: 10.1210/me.2005-0346. Epub 2005 Dec 29.
4
A novel nuclear role for the Vav3 nucleotide exchange factor in androgen receptor coactivation in prostate cancer.Vav3 核苷酸交换因子在前列腺癌雄激素受体共激活中的新型核作用。
Oncogene. 2012 Feb 9;31(6):716-27. doi: 10.1038/onc.2011.273. Epub 2011 Jul 18.
5
Vav3 oncogene activates estrogen receptor and its overexpression may be involved in human breast cancer.Vav3癌基因激活雌激素受体,其过表达可能与人乳腺癌有关。
BMC Cancer. 2008 Jun 2;8:158. doi: 10.1186/1471-2407-8-158.
6
Ligand-independent activation of androgen receptors by Rho GTPase signaling in prostate cancer.Rho GTPase信号通路在前列腺癌中对雄激素受体的非配体依赖性激活
Mol Endocrinol. 2008 Mar;22(3):597-608. doi: 10.1210/me.2007-0158. Epub 2007 Dec 13.
7
Targeting the Vav3 oncogene enhances docetaxel-induced apoptosis through the inhibition of androgen receptor phosphorylation in LNCaP prostate cancer cells under chronic hypoxia.靶向 Vav3 癌基因通过抑制慢性低氧下 LNCaP 前列腺癌细胞中雄激素受体磷酸化增强多西紫杉醇诱导的细胞凋亡。
Mol Cancer. 2013 Apr 8;12:27. doi: 10.1186/1476-4598-12-27.
8
Vav3 oncogene is involved in regulation of secretory phospholipase A2-IIa expression in prostate cancer.Vav3 癌基因参与调控前列腺癌中分泌型磷脂酶 A2-IIa 的表达。
Oncol Rep. 2011 Jun;25(6):1511-6. doi: 10.3892/or.2011.1237. Epub 2011 Mar 29.
9
Vav3 enhances androgen receptor splice variant activity and is critical for castration-resistant prostate cancer growth and survival.Vav3增强雄激素受体剪接变体活性,对去势抵抗性前列腺癌的生长和存活至关重要。
Mol Endocrinol. 2012 Dec;26(12):1967-79. doi: 10.1210/me.2012-1165. Epub 2012 Sep 28.
10
Novel interaction between the co-chaperone Cdc37 and Rho GTPase exchange factor Vav3 promotes androgen receptor activity and prostate cancer growth.新型共伴侣 Cdc37 与 Rho GTP 酶交换因子 Vav3 的相互作用促进雄激素受体活性和前列腺癌生长。
J Biol Chem. 2013 Feb 22;288(8):5463-74. doi: 10.1074/jbc.M112.390963. Epub 2012 Dec 31.

引用本文的文献

1
Evolution of androgen receptors contributes to species variation in androgenic regulation of communication signals in electric fishes.雄激素受体的进化导致电鱼通讯信号的雄激素调控在物种间存在差异。
Mol Cell Endocrinol. 2023 Dec 1;578:112068. doi: 10.1016/j.mce.2023.112068. Epub 2023 Sep 14.
2
The role of Vav3 expression for inflammation and cell death during experimental myocardial infarction.Vav3 表达在实验性心肌梗死中炎症和细胞死亡中的作用。
Clinics (Sao Paulo). 2023 Aug 14;78:100273. doi: 10.1016/j.clinsp.2023.100273. eCollection 2023.
3
Fatty acids homeostasis during fasting predicts protection from chemotherapy toxicity.
禁食过程中脂肪酸的动态平衡可预测对化疗毒性的保护作用。
Nat Commun. 2022 Sep 27;13(1):5677. doi: 10.1038/s41467-022-33352-3.
4
Inhibition of Vav3 gene can promote apoptosis of human gastric cancer cell line MGC803 by regulating ERK pathway.抑制Vav3基因可通过调节ERK信号通路促进人胃癌细胞系MGC803的凋亡。
Tumour Biol. 2016 Jun;37(6):7823-33. doi: 10.1007/s13277-015-4505-9. Epub 2015 Dec 22.
5
Genome-wide association study of susceptibility loci for breast cancer in Sardinian population.全基因组关联研究发现撒丁岛人群乳腺癌易感基因座。
BMC Cancer. 2015 May 10;15:383. doi: 10.1186/s12885-015-1392-9.
6
Vav family exchange factors: an integrated regulatory and functional view.Vav家族交换因子:综合调控与功能视角
Small GTPases. 2014;5(2):9. doi: 10.4161/21541248.2014.973757.
7
Inhibition of Vav3 could reverse the drug resistance of gastric cancer cells by downregulating JNK signaling pathway.抑制 Vav3 可以通过下调 JNK 信号通路逆转胃癌细胞的耐药性。
Cancer Gene Ther. 2014 Dec;21(12):526-31. doi: 10.1038/cgt.2014.59. Epub 2014 Nov 28.
8
Inhibition of gastric cancer cell growth and invasion through siRNA-mediated knockdown of guanine nucleotide exchange factor Vav3.通过小干扰RNA介导的鸟嘌呤核苷酸交换因子Vav3基因敲低抑制胃癌细胞生长和侵袭
Tumour Biol. 2014 Feb;35(2):1481-8. doi: 10.1007/s13277-013-1204-2. Epub 2013 Sep 27.
9
A novel nuclear role for the Vav3 nucleotide exchange factor in androgen receptor coactivation in prostate cancer.Vav3 核苷酸交换因子在前列腺癌雄激素受体共激活中的新型核作用。
Oncogene. 2012 Feb 9;31(6):716-27. doi: 10.1038/onc.2011.273. Epub 2011 Jul 18.
10
Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer.分泌型磷脂酶 A2-IIa 参与前列腺癌的进展,并且有可能作为前列腺癌的生物标志物。
Carcinogenesis. 2010 Nov;31(11):1948-55. doi: 10.1093/carcin/bgq188. Epub 2010 Sep 13.